Skip to main content
Swing Capital

Lyka Labs Ltd

NSE: LYKALABS BSE: 500259

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages[1]

₹60
52W: ₹44.1 — ₹129
PE 0 · Book ₹37 · +62% vs book
Market Cap₹214 Cr
Stock P/E—Price to Earnings
ROCE8.29%Return on Capital
ROE7.03%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has reduced debt.

Weaknesses

  • −Company has low interest coverage ratio.
  • −Company has a low return on equity of -0.12% over last 3 years.
  • −Earnings include an other income of Rs.3.86 Cr.

Shareholding Pattern

Promoters58.16%
FIIs0.29%
DIIs0.66%
Public40.89%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters58.11%58.11%58.11%58.16%▲0.058.16%58.16%58.16%58.16%
FIIs0.15%0.15%0.15%0.24%▲0.10.16%▼0.10.17%▲0.00.17%0.29%▲0.1
DIIs0.75%0.66%▼0.10.66%0.66%0.66%0.66%0.66%0.66%
Public40.99%41.08%▲0.141.07%▼0.040.93%▼0.141.02%▲0.140.99%▼0.040.99%40.89%▼0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales26.7631.4226.9830.141.1632.9230.5229.1832.9730.73
Expenses22.8225.5624.7626.0535.8227.8327.1125.836.1228.82
Operating Profit3.945.862.224.055.345.093.413.38-3.151.91
OPM %14.72%18.65%8.23%13.46%12.97%15.46%11.17%11.58%-9.55%6.22%
Net Profit-0.291.36-1.621.752.472.71.310.81-3.630.28
EPS ₹-0.090.41-0.490.490.690.760.370.23-1.020.08

AI Insights

Revenue Trend

TTM revenue at ₹123Cr, down 8.9% YoY. OPM at 4%.

Debt Position

Borrowings at ₹31Cr. Debt-to-equity ratio: 0.32x. Healthy balance sheet.

Capex Cycle

CWIP at ₹1Cr (1% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0.66% (+0.25pp change). FIIs: 0.29% (+0.12pp change). Promoters hold 58.16%.

Margin & Efficiency

ROCE improving from -1% (Jun 2014) to 8% (Mar 2025). Working capital days: 54.

Recent Announcements